The CCF Advisory Boards consist of key opinion leaders, scientists, clinicians and healthcare providers who are active in the education, treatment, clinical and basic research of cholangiocarcinoma and are committed to furthering the CCF mission. Advisory Board members serve to guide the CCF with a diversity of perspectives, providing assistance and insight into the vision and mission of the CCF from a medical/scientific perspective. In addition, the Advisory Boards provide guidance on strategic medical and scientific direction for the Executive Board of Directors.
Memorial Sloan-Kettering Cancer Center New York, New York
University of Manchester (Institute of Cancer Studies) Manchester, United Kingdom
University of California San Francisco, California
MD Anderson Cancer Center Houston, Texas
Harvard Medical School and the Massachusetts General Hospital Cancer Center Boston, Massachusetts
University of Pennsylvania Philadephia, Pennsylvania